NM_032447.5:c.3247C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_032447.5(FBN3):​c.3247C>T​(p.Arg1083Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0484 in 1,609,962 control chromosomes in the GnomAD database, including 3,311 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1083Q) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.049 ( 375 hom., cov: 32)
Exomes 𝑓: 0.048 ( 2936 hom. )

Consequence

FBN3
NM_032447.5 missense

Scores

3
6
9

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.94

Publications

18 publications found
Variant links:
Genes affected
FBN3 (HGNC:18794): (fibrillin 3) This gene encodes a memebr of the fibrillin protein family. Fibrillins are extracellular matrix molecules that assemble into microfibrils in many connective tissues. This gene is most highly expressed in fetal tissues and its protein product is localized to extracellular microfibrils of developing skeletal elements, skin, lung, kidney, and skeletal muscle. This gene is potentially involved in Weill-Marchesani syndrome. [provided by RefSeq, Mar 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0031781197).
BP6
Variant 19-8118987-G-A is Benign according to our data. Variant chr19-8118987-G-A is described in ClinVar as Benign. ClinVar VariationId is 1540834.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.174 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FBN3NM_032447.5 linkc.3247C>T p.Arg1083Trp missense_variant Exon 26 of 64 ENST00000600128.6 NP_115823.3 Q75N90A8KAY2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FBN3ENST00000600128.6 linkc.3247C>T p.Arg1083Trp missense_variant Exon 26 of 64 1 NM_032447.5 ENSP00000470498.1 Q75N90
FBN3ENST00000270509.6 linkc.3247C>T p.Arg1083Trp missense_variant Exon 25 of 63 1 ENSP00000270509.2 Q75N90
FBN3ENST00000601739.5 linkc.3247C>T p.Arg1083Trp missense_variant Exon 26 of 64 1 ENSP00000472324.1 Q75N90
FBN3ENST00000651877.1 linkc.3373C>T p.Arg1125Trp missense_variant Exon 26 of 64 ENSP00000498507.1 A0A494C0D8

Frequencies

GnomAD3 genomes
AF:
0.0494
AC:
7519
AN:
152160
Hom.:
371
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0141
Gnomad AMI
AF:
0.0252
Gnomad AMR
AF:
0.141
Gnomad ASJ
AF:
0.0279
Gnomad EAS
AF:
0.184
Gnomad SAS
AF:
0.0416
Gnomad FIN
AF:
0.0816
Gnomad MID
AF:
0.0506
Gnomad NFE
AF:
0.0367
Gnomad OTH
AF:
0.0667
GnomAD2 exomes
AF:
0.0713
AC:
17874
AN:
250778
AF XY:
0.0667
show subpopulations
Gnomad AFR exome
AF:
0.0129
Gnomad AMR exome
AF:
0.190
Gnomad ASJ exome
AF:
0.0285
Gnomad EAS exome
AF:
0.184
Gnomad FIN exome
AF:
0.0786
Gnomad NFE exome
AF:
0.0352
Gnomad OTH exome
AF:
0.0687
GnomAD4 exome
AF:
0.0483
AC:
70358
AN:
1457684
Hom.:
2936
Cov.:
31
AF XY:
0.0479
AC XY:
34675
AN XY:
724258
show subpopulations
African (AFR)
AF:
0.0114
AC:
381
AN:
33424
American (AMR)
AF:
0.190
AC:
8498
AN:
44614
Ashkenazi Jewish (ASJ)
AF:
0.0269
AC:
702
AN:
26108
East Asian (EAS)
AF:
0.206
AC:
8144
AN:
39598
South Asian (SAS)
AF:
0.0481
AC:
4140
AN:
86118
European-Finnish (FIN)
AF:
0.0738
AC:
3926
AN:
53186
Middle Eastern (MID)
AF:
0.0528
AC:
304
AN:
5760
European-Non Finnish (NFE)
AF:
0.0371
AC:
41127
AN:
1108738
Other (OTH)
AF:
0.0521
AC:
3136
AN:
60138
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
3236
6472
9708
12944
16180
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1730
3460
5190
6920
8650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0494
AC:
7528
AN:
152278
Hom.:
375
Cov.:
32
AF XY:
0.0530
AC XY:
3944
AN XY:
74470
show subpopulations
African (AFR)
AF:
0.0140
AC:
584
AN:
41582
American (AMR)
AF:
0.141
AC:
2160
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.0279
AC:
97
AN:
3472
East Asian (EAS)
AF:
0.183
AC:
949
AN:
5174
South Asian (SAS)
AF:
0.0412
AC:
199
AN:
4830
European-Finnish (FIN)
AF:
0.0816
AC:
866
AN:
10618
Middle Eastern (MID)
AF:
0.0544
AC:
16
AN:
294
European-Non Finnish (NFE)
AF:
0.0367
AC:
2496
AN:
68018
Other (OTH)
AF:
0.0655
AC:
138
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
343
686
1029
1372
1715
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
82
164
246
328
410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0430
Hom.:
759
Bravo
AF:
0.0549
TwinsUK
AF:
0.0396
AC:
147
ALSPAC
AF:
0.0319
AC:
123
ESP6500AA
AF:
0.0145
AC:
64
ESP6500EA
AF:
0.0387
AC:
333
ExAC
AF:
0.0632
AC:
7670
Asia WGS
AF:
0.101
AC:
350
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

FBN3-related disorder Benign:1
Feb 21, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.091
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.25
CADD
Uncertain
26
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.55
D;D;D
Eigen
Benign
-0.40
Eigen_PC
Benign
-0.38
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Uncertain
0.96
.;.;D
MetaRNN
Benign
0.0032
T;T;T
MetaSVM
Benign
-0.95
T
MutationAssessor
Uncertain
2.2
M;M;M
PhyloP100
1.9
PrimateAI
Benign
0.26
T
PROVEAN
Pathogenic
-6.9
.;D;.
REVEL
Uncertain
0.29
Sift
Pathogenic
0.0
.;D;.
Sift4G
Pathogenic
0.0
D;D;D
Polyphen
0.039
B;B;B
Vest4
0.38
MPC
0.68
ClinPred
0.086
T
GERP RS
0.39
Varity_R
0.80
gMVP
0.73
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35579498; hg19: chr19-8183871; COSMIC: COSV54457918; API